Last update 26 Aug 2026

HY-035

Overview

Basic Info

Drug Type
Universal CAR-T
Synonyms
HY 035, HY035
Target
CD7
Action
inhibitors
Mechanism
CD7 inhibitors(T-cell antigen CD7 inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases+ [1]
Active Indication
Acute Myeloid LeukemiaCD7 positive Hematologic NeoplasmsRefractory T Lymphoblastic Lymphoma+ [1]
Inactive Indication-
Originator Organization
Juventas Cell Therapy Ltd.Juventas Cell Therapy Ltd.
Active Organization
Juventas Cell Therapy Ltd.Juventas Cell Therapy Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with HY-035
NCT07784309
/ Enrolling by invitationPhase 1IIT
A Clinical Study on the Safety and Efficacy of HY035 Cell Injection in the Treatment of CD7-positive Relapsed or Refractory Hematologic Malignancies
100 Clinical Results associated with HY-035
Login to view more data
100 Translational Medicine associated with HY-035
Login to view more data
100 Patents (Medical) associated with HY-035
Login to view more data
100 Deals associated with HY-035
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Myeloid LeukemiaPhase 1
China
Juventas Cell Therapy Ltd.Juventas Cell Therapy Ltd.
15 Aug 2026
CD7 positive Hematologic NeoplasmsPhase 1
China
Juventas Cell Therapy Ltd.Juventas Cell Therapy Ltd.
15 Aug 2026
Refractory T Lymphoblastic LymphomaPhase 1
China
Juventas Cell Therapy Ltd.Juventas Cell Therapy Ltd.
15 Aug 2026
T-Cell LymphomaPhase 1
China
Juventas Cell Therapy Ltd.Juventas Cell Therapy Ltd.
15 Aug 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free